Delivery Order SPE2DR25D1109-SPE2DR26FFJ9E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in a quantity of 100 units on November 13, 2025. This firm fixed-price delivery order, valued at $2,715.74, is scheduled for completion by November 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,715.74 delivery order to AmerisourceBergen Drug Corp for Levorphanol 2 mg tablets (100 count) under a firm fixed price contract. The order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive, non-set-aside award to supply this pharmaceutical product to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Levorphanol 2 mg tablets (100-count) with a ceiling value of $2,715.74. This is a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $4,782.46 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location for this pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Levorphanol Tablets 2mg, a controlled pharmaceutical product used in pain management. This firm fixed-price delivery order, valued at $8,422.31, was awarded without set-aside designation through competitive procurement and is scheduled for completion by June 25, 2025. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,715.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Levorphanol 2 mg, with an ultimate completion date of December 31, 2025. This non-set-aside award was made competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime contractor,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Levorphanol Tablets 2mg, a pharmaceutical product used in pain management and medical treatment. This non-set-aside, competitively awarded contract is valued at $5,270.16 with a firm fixed price structure and an ultimate completion date of December 24, 2025. The award was issued on December 23, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,854.05 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency Troop Support Medical awarded a $3,776.51 firm fixed price delivery order to Amerisourcebergen Drug Corp for 2mg levorphanol tablets. The unrestricted award is for delivery of the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by October 18, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor supporting the medical supply needs of the U.S. armed forces through the...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFJ9EDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,073.61 on December 31, 2025, for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This competitive award, with no set-aside designation, is classified as a firm fixed price delivery order with an ultimate completion date of January 2, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement that enables global pharmaceutical support to military healthcare systems through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to defense and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency encompasses diverse pharmaceutical products across multiple therapeutic domains, from specialty medications to vaccines and medical devices. As a child contract under the SPE2DX indefinite delivery vehicle, this delivery order reflects the company's ongoing role in supporting the military healthcare supply chain with essential pharmaceutical commodities on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/30/25 |